Request for Covid-19 Impact Assessment of this Report
The United States Herpes Simplex Virus (HSV) Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Herpes Simplex Virus (HSV) Vaccines market, reaching US$ million by the year 2028. As for the Europe Herpes Simplex Virus (HSV) Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Herpes Simplex Virus (HSV) Vaccines players cover Sanofi, GlaxoSmithKline, Genocea Biosciences, and Vical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus (HSV) Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
GEN-003
VCL-HB01
HSV529
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
HSV-1 (Oral Herpes)
HSV-2 (Genital Herpes)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
GlaxoSmithKline
Genocea Biosciences
Vical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Herpes Simplex Virus (HSV) Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
2.2.1 GEN-003
2.2.2 VCL-HB01
2.2.3 HSV529
2.2.4 Others
2.3 Herpes Simplex Virus (HSV) Vaccines Sales by Type
2.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2017-2022)
2.4 Herpes Simplex Virus (HSV) Vaccines Segment by Application
2.4.1 HSV-1 (Oral Herpes)
2.4.2 HSV-2 (Genital Herpes)
2.5 Herpes Simplex Virus (HSV) Vaccines Sales by Application
2.5.1 Global Herpes Simplex Virus (HSV) Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2017-2022)
3 Global Herpes Simplex Virus (HSV) Vaccines by Company
3.1 Global Herpes Simplex Virus (HSV) Vaccines Breakdown Data by Company
3.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2022)
3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company
3.4 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Location Distribution
3.4.2 Players Herpes Simplex Virus (HSV) Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Herpes Simplex Virus (HSV) Vaccines by Geographic Region
4.1 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Geographic Region
4.2 World Historic Herpes Simplex Virus (HSV) Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue by Country/Region
4.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.4 APAC Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.5 Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth
4.6 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth
5 Americas
5.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country
5.1.1 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)
5.1.2 Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)
5.2 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type
5.3 Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region
6.1.1 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022)
6.1.2 APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022)
6.2 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type
6.3 APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Herpes Simplex Virus (HSV) Vaccines by Country
7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)
7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines by Country
8.1.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type
8.3 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines
10.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
10.4 Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herpes Simplex Virus (HSV) Vaccines Distributors
11.3 Herpes Simplex Virus (HSV) Vaccines Customer
12 World Forecast Review for Herpes Simplex Virus (HSV) Vaccines by Geographic Region
12.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Forecast by Region
12.1.1 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Region (2023-2028)
12.1.2 Global Herpes Simplex Virus (HSV) Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Type
12.7 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Offered
13.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Offered
13.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Genocea Biosciences
13.3.1 Genocea Biosciences Company Information
13.3.2 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Offered
13.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Genocea Biosciences Main Business Overview
13.3.5 Genocea Biosciences Latest Developments
13.4 Vical
13.4.1 Vical Company Information
13.4.2 Vical Herpes Simplex Virus (HSV) Vaccines Product Offered
13.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Vical Main Business Overview
13.4.5 Vical Latest Developments
14 Research Findings and Conclusion
Table 1. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Herpes Simplex Virus (HSV) Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of GEN-003
Table 4. Major Players of VCL-HB01
Table 5. Major Players of HSV529
Table 6. Major Players of Others
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
Table 9. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & ($ million)
Table 10. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2022)
Table 11. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022)
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2022)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales by Company (2020-2022) & (K Units)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Company (2020-2022)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company (2020-2022)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Herpes Simplex Virus (HSV) Vaccines Producing Area Distribution and Sales Area
Table 23. Players Herpes Simplex Virus (HSV) Vaccines Products Offered
Table 24. Herpes Simplex Virus (HSV) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Geographic Region (2017-2022)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country/Region (2017-2022)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)
Table 37. Americas Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
Table 41. Americas Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 42. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Table 43. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)
Table 45. APAC Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2022)
Table 47. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 48. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
Table 49. APAC Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 50. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)
Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)
Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 56. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
Table 57. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 58. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Herpes Simplex Virus (HSV) Vaccines
Table 68. Key Market Challenges & Risks of Herpes Simplex Virus (HSV) Vaccines
Table 69. Key Industry Trends of Herpes Simplex Virus (HSV) Vaccines
Table 70. Herpes Simplex Virus (HSV) Vaccines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 73. Herpes Simplex Virus (HSV) Vaccines Customer List
Table 74. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Forecast by Region
Table 76. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Herpes Simplex Virus (HSV) Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 94. Sanofi Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Offered
Table 96. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Sanofi Main Business
Table 98. Sanofi Latest Developments
Table 99. GlaxoSmithKline Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Offered
Table 101. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Latest Developments
Table 104. Genocea Biosciences Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Offered
Table 106. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Genocea Biosciences Main Business
Table 108. Genocea Biosciences Latest Developments
Table 109. Vical Basic Information, Herpes Simplex Virus (HSV) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Vical Herpes Simplex Virus (HSV) Vaccines Product Offered
Table 111. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Vical Main Business
Table 113. Vical Latest Developments
List of Figures
Figure 1. Picture of Herpes Simplex Virus (HSV) Vaccines
Figure 2. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of GEN-003
Figure 10. Product Picture of VCL-HB01
Figure 11. Product Picture of HSV529
Figure 12. Product Picture of Others
Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2021
Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2022)
Figure 15. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-1 (Oral Herpes)
Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-1 (Oral Herpes) (2017-2022) & (K Units)
Figure 17. Herpes Simplex Virus (HSV) Vaccines Consumed in HSV-2 (Genital Herpes)
Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Market: HSV-2 (Genital Herpes) (2017-2022) & (K Units)
Figure 19. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2022)
Figure 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application in 2021
Figure 21. Herpes Simplex Virus (HSV) Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Company in 2021
Figure 23. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Geographic Region in 2021
Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)
Figure 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country/Region in 2021
Figure 27. Americas Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)
Figure 28. Americas Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. APAC Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)
Figure 30. APAC Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Europe Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)
Figure 32. Europe Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. Americas Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021
Figure 36. Americas Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021
Figure 37. United States Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region in 2021
Figure 42. APAC Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Regions in 2021
Figure 43. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021
Figure 50. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021
Figure 51. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country in 2021
Figure 58. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Herpes Simplex Virus (HSV) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Herpes Simplex Virus (HSV) Vaccines in 2021
Figure 64. Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
Figure 65. Industry Chain Structure of Herpes Simplex Virus (HSV) Vaccines
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...